Name
BIOLOGICS PANEL DISCUSSION
Date & Time
Thursday, June 1, 2017, 11:15 AM - 12:00 PM
Description
CHAMPIONING CUTTING EDGE INNOVATION WITH ROBUST PATENT PROTECTION
Who's setting the agenda on biologics?
  • Ensuring effective protection for antibodies
  • Is it advisable to use trade secrets protection rather than patenting?
  • Do biosimilar applicants have to join in the patent dance?
Moderator: 
Barbara Fiacco, Second Vice President, American Intellectual Property Law Association
 
Panellists: 
Brendan O'Malley, Partner, Fitzpatrick Cella Harper & Scinto
Larry Coury, Senior Director of Dispute Resolution, Regeneron
Ahmed Mousa, VP Licensing, IP & Legal Affairs, Pieris Pharmaceuticals 
Paul Inman, Partner, Gowling WLG